Investigators summarize the prevalence and molecular mechanisms behind HLA-I loss in colorectal cancer (CRC), and discuss HLA-I expression/loss in the context of the newly identified CRC molecular subtypes.
[Cellular & Molecular Immunology]
Anderson, P., Aptsiauri, N., Ruiz-Cabello, F., & Garrido, F. (2021). HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy. Cellular & Molecular Immunology, 1–10. https://doi.org/10.1038/s41423-021-00634-7 Cite
0